<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26827" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pediatric Diabetic Ketoacidosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>EL-Mohandes</surname>
            <given-names>Noha</given-names>
          </name>
          <aff>UHND</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yee</surname>
            <given-names>Garrett</given-names>
          </name>
          <aff>The Permanente Medical Group</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhutta</surname>
            <given-names>Beenish S.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huecker</surname>
            <given-names>Martin R.</given-names>
          </name>
          <aff>University of Louisville</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noha EL-Mohandes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Garrett Yee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Beenish Bhutta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Martin Huecker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26827.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Diabetic ketoacidosis (DKA) is a serious complication of relative insulin deficiency affecting primarily type-1 diabetes mellitus (DM). DKA can occur in type-2 DM when insulin levels fall far behind the body&#x02019;s needs. DKA is so named due to high levels of water-soluble ketone bodies (KBs), leading to an acidotic physiologic state. Ketone bodies, while always present in the blood, increase to pathologic levels when the body cannot utilize glucose: low blood glucose levels during fasting, starvation, vigorous exercise, or secondary to a defect in insulin production. This activity reviews the etiology, presentation, evaluation, and management of diabetic ketoacidosis in the pediatric population and examines the role of the interprofessional team in evaluating, diagnosing, and managing the condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of pediatric diabetic ketoacidosis.</p></list-item><list-item><p>Review the evaluation of a patient with pediatric diabetic ketoacidosis, including all necessary laboratory tests.</p></list-item><list-item><p>Summarize the management options for diabetic ketoacidosis.</p></list-item><list-item><p>Explain modalities to improve care coordination among interprofessional team members to improve outcomes for pediatric patients affected by diabetic ketoacidosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26827&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26827">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26827.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Diabetic ketoacidosis (DKA) is a serious complication of relative insulin deficiency affecting primarily type-1 diabetes mellitus (DM). DKA can occur in type-2 DM when insulin levels fall far behind the body's needs. DKA is so named due to high levels of water-soluble ketone bodies (KBs), leading to an acidotic physiologic state.<xref ref-type="bibr" rid="article-26827.r1">[1]</xref><xref ref-type="bibr" rid="article-26827.r2">[2]</xref></p>
        <p>According to the International Society for Pediatric and Adolescent Diabetes, DKA is defined by the presence of <bold>all</bold> of the following in a patient with diabetes:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Hyperglycemia</bold> &#x02013; Blood glucose &#x0003e;200 mg/dL (11 mmol/L)</p>
          </list-item>
          <list-item>
            <p><bold>Metabolic acidosis</bold> &#x02013; Venous pH &#x0003c;7.3 or serum bicarbonate &#x0003c;15 mEq/L (15 mmol/L)</p>
          </list-item>
          <list-item>
            <p><bold>Ketosis</bold> &#x02013; Presence of ketones in the blood (&#x0003e;3 mmol/L beta-hydroxybutyrate) or urine ("moderate or large" urine ketones)<xref ref-type="bibr" rid="article-26827.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>Produced by the liver during fatty acid metabolism, KBs can be utilized by the brain, cardiac, and skeletal muscle tissues as a fuel when the body is deficient in or cannot effectively import glucose.<xref ref-type="bibr" rid="article-26827.r4">[4]</xref><xref ref-type="bibr" rid="article-26827.r5">[5]</xref></p>
      </sec>
      <sec id="article-26827.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Ketone bodies, while always present in the blood, increase to pathologic levels when the body cannot utilize glucose (e.g., fasting, starvation, vigorous exercise, or secondary to a defect in insulin production). In type-2 DM, insulin production may be normal but below the level needed to shunt glucose into cells.<xref ref-type="bibr" rid="article-26827.r6">[6]</xref><xref ref-type="bibr" rid="article-26827.r7">[7]</xref></p>
        <p>Most body fat is stored as triglyceride (TG). When the body's glucose storage sites become depleted, the liver dismantles the TG into three fatty acids (FAs) and a glycerol molecule. The FAs can undergo oxidation while glycerol&#x000a0;converts to glucose. In the presence of enough insulin, this glucose will be consumed as energy. In the absence of insulin, the body cannot utilize the glucose released from the glycerol metabolism; unused glucose rises to dangerous levels, with spillover into the urine.</p>
        <p>When the blood glucose is&#x000a0;low or cannot be used due to a lack of insulin,&#x000a0;ketones are the major energy source for the brain. The brain does not store fuel&#x000a0;and can only utilize glucose and ketones for fuel.</p>
        <p>In contrast, skeletal muscle&#x000a0;stores and can utilize glycogen. Approximately 70% of the total body glycogen is stored in muscles and can be converted, when needed, to glucose via&#x000a0;glycogenolysis.</p>
      </sec>
      <sec id="article-26827.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>DKA is frequently present at diagnosis of type 1 diabetes (in approximately 3% percent of children in the United States and Canada) and, along with its complications, is the most common cause of hospitalization, mortality, and morbidity in children with type 1 diabetes mellitus.<xref ref-type="bibr" rid="article-26827.r8">[8]</xref> The fatality rate is approximately 0.15-0.31% of cases. DKA in children with type 2 diabetes is also observed but at lower rates.<xref ref-type="bibr" rid="article-26827.r9">[9]</xref></p>
        <p><bold>DKA at initial presentation of type 1 diabetes mellitus:&#x000a0;</bold>DKA occurs at the time of diagnosis of type 1 diabetes in approximately 30 percent of children in the United States and Canada.<xref ref-type="bibr" rid="article-26827.r10">[10]</xref>&#x000a0;Factors that increase the likelihood of DKA at the initial presentation of type 1 diabetes in children are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Young age (&#x0003c;5 years of age and especially &#x0003c;2 years)</p>
          </list-item>
          <list-item>
            <p>Ethnic minority</p>
          </list-item>
          <list-item>
            <p>Low socioeconomic status</p>
          </list-item>
          <list-item>
            <p>Children living in countries with a low prevalence of type 1 diabetes</p>
          </list-item>
          <list-item>
            <p>Ethnic minority</p>
          </list-item>
          <list-item>
            <p>Delayed diagnosis of diabetes<xref ref-type="bibr" rid="article-26827.r11">[11]</xref><xref ref-type="bibr" rid="article-26827.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>The importance of socioeconomic status was observed in a review of 139 patients with newly diagnosed type 1 diabetes mellitus attended at a single center in the United States.<xref ref-type="bibr" rid="article-26827.r13">[13]</xref>&#x000a0;In addition, the frequency of DKA at the presentation of type 1 diabetes is shown to be inversely related to the prevalence of type 1 diabetes in the population, reflecting a greater frequency of missed diagnoses of type 1 diabetes.<xref ref-type="bibr" rid="article-26827.r14">[14]</xref></p>
        <p><bold>DKA in established type 1 diabetes mellitus:</bold>&#x000a0;In children with an established diagnosis of type 1 diabetes, DKA occurs at an annual rate of 6 to 8%.<xref ref-type="bibr" rid="article-26827.r15">[15]</xref><xref ref-type="bibr" rid="article-26827.r16">[16]</xref></p>
        <p>The following factors contribute to the development of DKA:</p>
        <list list-type="bullet">
          <list-item>
            <p>Poor metabolic control</p>
          </list-item>
          <list-item>
            <p>Peripubertal and pubertal adolescent girls</p>
          </list-item>
          <list-item>
            <p>Gastroenteritis with vomiting and dehydration</p>
          </list-item>
          <list-item>
            <p>History of psychiatric disorders (including eating disorders) or family discord</p>
          </list-item>
          <list-item>
            <p>Limited access to medical care (underinsured)</p>
          </list-item>
          <list-item>
            <p>Omission of insulin, including failure of an insulin pump</p>
          </list-item>
        </list>
        <p>In a large prospective study in the United States, almost 60 percent of DKA episodes in children with established diabetes occurred in only 5 percent of all children.<xref ref-type="bibr" rid="article-26827.r15">[15]</xref>&#x000a0;Similar findings were reported in the United Kingdom.<xref ref-type="bibr" rid="article-26827.r8">[8]</xref></p>
        <p><bold>DKA in type 2 diabetes mellitus:</bold>&#x000a0;Ketosis and DKA can occur less frequently in children with type 2 diabetes and are usually observed mainly in African American adolescents with obesity.<xref ref-type="bibr" rid="article-26827.r17">[17]</xref>&#x000a0;About 13 percent had type 2 diabetes in a retrospective review of 69 patients (9 to 18 years of age) who presented with DKA.<xref ref-type="bibr" rid="article-26827.r9">[9]</xref></p>
      </sec>
      <sec id="article-26827.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The physiologic disturbance in DKA involves several interrelated processes:</p>
        <list list-type="order">
          <list-item>
            <p>Hyperglycemia is present, which leads to serum hyperosmolarity and osmotic diuresis.</p>
          </list-item>
          <list-item>
            <p>Glucosuria is the precursor to osmotic diuresis, hyperosmolarity, and dehydration. Free water losses can be substantial, with decompensation and impaired renal function.</p>
          </list-item>
          <list-item>
            <p>Ketones accumulate and cause metabolic acidosis. Compensatory hyperventilation eliminates carbon dioxide.</p>
          </list-item>
          <list-item>
            <p>Approximate potassium deficits in children with DKA are 3 to 6 mEq/kg. However, serum potassium levels are usually normal or slightly elevated at presentation due to the shift of potassium ions from the intracellular to extracellular space. Osmotic diuresis, elevated aldosterone concentrations in response to intravascular volume depletion, and ketoacid excretion may also result in urinary potassium loss.</p>
          </list-item>
          <list-item>
            <p>The measured serum sodium is reduced by 1.6 mEq/L for every 100 mg/dL (5.5 mEq/L) increase in the blood glucose concentration above 100 mg/dL leading to pseudohyponatermia.<xref ref-type="bibr" rid="article-26827.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Glucosuria-induced osmotic diuresis also causes phosphate deficit in children. However, the serum phosphate concentration is usually normal or even slightly elevated initially&#x000a0;as&#x000a0;both metabolic acidosis and insulin deficiency cause extracellular phosphate&#x000a0;shift. As this transcellular shift reverses during DKA treatment, phosphate levels typically decline.<xref ref-type="bibr" rid="article-26827.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Elevated blood urea nitrogen (BUN) concentration may be found in patients with DKA, which correlates with the degree of hypovolemia. Acute increases in serum creatinine reflecting acute kidney injury (AKI) may also be observed.</p>
          </list-item>
        </list>
        <p>
<bold>Ketoacidosis</bold>
</p>
        <p>Glucose is the primary carbon-based substrate in blood necessary for the production of adenosine triphosphate (ATP), which is the energy currency of cells after glucose is metabolized during glycolysis, Kreb's cycle, and the electron transport chain. Ketone bodies are fat-derived fuels used by tissues at the time of limited glucose availability. Hepatic generation of ketone bodies is usually stimulated by the combination of low insulin levels and high counter-regulatory hormone levels, including glucagon.<xref ref-type="bibr" rid="article-26827.r20">[20]</xref></p>
        <p>Deficiency and resistance (e.g., due to high catecholamine levels during physiological stress) lead to an unfavorable ratio of insulin to glucagon that activates hormone-sensitive lipase, which breaks down triglycerides in peripheral stores, releasing long-chain fatty acids and glycerol. The fatty acids, mainly bound to albumin, are transported to the splanchnic bed and taken up by hepatocytes. The fatty acids undergo beta-oxidation in the hepatic mitochondria and, by linking the fatty acid to coenzyme A (CoA), generate acetyl-CoA. The combination of low insulin and increased glucagon activity in the liver cells leads to the accelerated entry of the acyl-CoA into the mitochondria, mediated by a pair of carnitine palmityl transferase reactions.<xref ref-type="bibr" rid="article-26827.r21">[21]</xref><xref ref-type="bibr" rid="article-26827.r22">[22]</xref></p>
        <p>Acetyl coenzyme A can have one of three fates:</p>
        <list list-type="order">
          <list-item>
            <p>Enter the Krebs cycle to be oxidized to carbon dioxide (CO2) and water (H2O), forming adenosine triphosphate (ATP)</p>
          </list-item>
          <list-item>
            <p>Used to synthesize fatty acids in the cytoplasm</p>
          </list-item>
          <list-item>
            <p>Enter the ketogenic metabolic path to form acetoacetic acid</p>
          </list-item>
        </list>
        <p>With the generation of large quantities of acetyl-CoA in the more severe forms of each of these conditions, the oxidative capacity of the Krebs cycle gets saturated, and there is a spillover entry of acetyl-CoA into the ketogenic pathway and subsequent generation of acetoacetic acid, which is the first "ketone body.". The acetoacetic acid may then be reduced to beta-hydroxybutyric acid, which is also an organic acid, or nonenzymatically decarboxylated to acetone, which is not an acid.<xref ref-type="bibr" rid="article-26827.r23">[23]</xref> Acetone does not convert back to acetyl-CoA; instead excreted through urine or exhaled.&#x000a0;Through this process, ketones provide an alternate water-soluble energy source when glucose availability is reduced.</p>
      </sec>
      <sec id="article-26827.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Diabetes mellitus is a chronic illness; episodes of DKA recur in poorly controlled patients. It is difficult to characterize the consequences of&#x000a0;repeated episodes, but chronically elevated&#x000a0;HbA1c measurements predict micro-vascular and macro-vascular complications of diabetes.</p>
        <p>Up to 1% of DKA patients will have cerebral edema due to rapid osmolar shifts. Look for signs of sudden increased&#x000a0;intracranial pressure: bradycardia, headache, papilledema, irritability, rising blood pressure, and decreasing Glasgow coma scale (GCS). Cerebral edema mortality approaches 25%. Survivors suffer significant neurological morbidity.&#x000a0;</p>
      </sec>
      <sec id="article-26827.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Three ketone molecules predominate in human physiology: beta-hydroxybutyrate (BHB), acetoacetate, and acetone.</p>
        <p>Beta-hydroxybutyrate represents the most precise approach to measuring the severity of DKA, making up roughly 75% of ketones in DKA. Whole blood ketone test strips and serum laboratory tests quantify BHB. Most urine strips test for acetoacetate and acetone.</p>
        <p>BHB can be confirmed in the blood up to 24 hours before acetone and acetoacetate appear in the urine, as BHB is converted into these molecules. Therefore, urine ketone testing can increase even after proper DKA treatment ceases the formation of BHB. Acetone, which is stored in adipose tissue, is slowly released in the blood and excreted in the urine.</p>
        <p>
<bold>Serum Ketone Levels</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Less than 0.6 mmol/L=normal</p>
          </list-item>
          <list-item>
            <p>Between 0.6&#x000a0;mmol/L&#x000a0;to 1.5 mmol/L=low to moderate</p>
          </list-item>
          <list-item>
            <p>Between 1.6&#x000a0;mmol/L&#x000a0;to 3.0 mmol/L=high with a risk of developing DKA</p>
          </list-item>
          <list-item>
            <p>Over 3.0 mmol/L: Likely DKA, requires immediate emergency treatment<xref ref-type="bibr" rid="article-26827.r24">[24]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Urine Ketone Strip Levels</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Having no ketones in the urine is normal.</p>
          </list-item>
          <list-item>
            <p>One plus (+) ketones in urine ketones strips are equal to low/moderate blood ketones levels.</p>
          </list-item>
          <list-item>
            <p>Two plus (++) ketones in urine are equal to a high blood level of ketones.</p>
          </list-item>
          <list-item>
            <p>Three plus (+++) ketones in urine are equal to severe blood ketones.</p>
          </list-item>
          <list-item>
            <p>False-positive ketones in urine can occur with the intake of some medications like captopril and valproate. False-negative ketones in urine can occur&#x000a0;with expired urine strips or delayed urine testing. As mentioned above, blood ketone levels should be the first&#x000a0;choice to monitor the treatment. If blood testing is unavailable, urine ketone levels can help make the diagnosis but are of low yield in monitoring response to treatment.<xref ref-type="bibr" rid="article-26827.r25">[25]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26827.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Ill patients with Type-1 DM should be evaluated for DKA, which can coexist with or be triggered by other acute illnesses (infection, trauma, etc.). There may be a history of polydipsia, polyuria, polyphagia (early), anorexia (late), weight loss, fatigue, or recurrent infection. Patients and parents may also report poor school performance, lack of concentration, altered mental status, and confusion as well.</p>
        <p>Commonly new-onset type 1 diabetic children appear thin and dehydrated on examination. Dehydration, thirst, and polyuria&#x000a0;are common at the time of presentation due to glucosuria and osmotic diuresis.</p>
        <p>Abdominal tenderness, abdominal pain, nausea, and vomiting are also common; some children in the first DKA episode may be misdiagnosed&#x000a0;with viral gastroenteritis.</p>
        <p>Patients with&#x000a0;metabolic acidosis classically display&#x000a0;rapid, deep breathing (Kussmaul respirations). The breath may have a fruity odor due to respiratory acetone elimination.</p>
        <p>Neurologic findings range from alert, to lethargic and drowsy, to comatose correlated with&#x000a0;the extent of acidosis.<xref ref-type="bibr" rid="article-26827.r26">[26]</xref></p>
      </sec>
      <sec id="article-26827.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>DKA is definitively diagnosed by serology showing&#x000a0;metabolic acidosis and hyperglycemia. Ketone testing can be helpful but is not necessary.</p>
        <p>Several&#x000a0;point-of-care&#x000a0;and laboratory tests aid in the diagnosis of DKA.<xref ref-type="bibr" rid="article-26827.r27">[27]</xref>&#x000a0;These include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Anion gap:</bold> The anion gap is calculated as follows: (Na+K)-(Cl+HCO3). Ketoacids (primarily BHB) are unmeasured ions, leading to the &#x0201c;gap&#x0201d; in anions. The AG is normally between 6&#x000a0;mEq/L to&#x000a0;12 mEq/L, with levels above 15 typically present in DKA.<xref ref-type="bibr" rid="article-26827.r28">[28]</xref><xref ref-type="bibr" rid="article-26827.r29">[29]</xref><xref ref-type="bibr" rid="article-26827.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Blood glucose:</bold> It is usually above 200 mg/dL (11 mmol/l) and may be above 1000 mg/dL. Pediatric patients have&#x000a0;DKA with relatively&#x000a0;mild&#x000a0;elevations in blood glucose.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Serum BHB concentration:</bold> BHB is usually above&#x000a0;31 mg/dL in these patients.<xref ref-type="bibr" rid="article-26827.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>
<bold>Blood urea nitrogen (BUN) and creatinine</bold>
</p>
          </list-item>
          <list-item>
            <p>
<bold>
<bold>Serum electrolytes</bold>
</bold>
</p>
          </list-item>
          <list-item>
            <p><bold>Venous pH and partial pressure of carbon dioxide (pCO2):</bold> A pH below 7.2 portends a worse prognosis and often indicates the need for intensive care unit admission.</p>
          </list-item>
          <list-item>
            <p><bold>Urinary ketone:</bold> Nitroprusside test strip reacts with acetoacetate and acetone but not BHB. Though less accurate and precise, many health centers use urine test strips for diagnosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Blood lactate concentration:</bold>&#x000a0;The presence of lactate can help rule out lactic acidosis. It is also an important prognostic marker in the presence of sepsis, which may be a precipitating cause in many DKA patients.</p>
          </list-item>
          <list-item>
            <p><bold>Hemoglobin A1c (HbA1c):</bold> This is helpful&#x000a0;in patients with known diabetes to evaluate the degree of glucose control.</p>
          </list-item>
          <list-item>
            <p><bold>Diabetes-associated antibodies:</bold> Glutamic acid decarboxylase antibodies, insulin autoantibodies, islet cell antibodies, and zinc transporter 8 antibodies are not useful for managing DKA. However, their presence confirms the diagnosis of type 1 diabetes mellitus in 80 to 85% of&#x000a0;new patients.<xref ref-type="bibr" rid="article-26827.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p><bold>C-peptide levels:</bold> It is a useful marker of beta-cell function, allowing discrimination between insulin-sufficient and insulin-deficient individuals with diabetes. A value of less than 0.2&#x000a0;nmol/l is associated with a diagnosis of type 1 diabetes mellitus (T1DM).</p>
          </list-item>
        </list>
        <p>DKA can be categorized as mild, moderate, and severe based on the following criteria:</p>
        <table-wrap id="article-26827.table0" position="float" orientation="portrait">
          <table style="width: 625.078125px; height: 42px;" cellspacing="0">
            <tbody>
              <tr style="height: 22px;">
                <td style="width: 127px; height: 22px;" rowspan="1" colspan="1">
<bold>Features</bold>
</td>
                <td style="width: 117px; height: 22px;" rowspan="1" colspan="1">
<bold>
<bold>Mild DKA</bold>
</bold>
</td>
                <td style="width: 117px; height: 22px;" rowspan="1" colspan="1">
<bold>
<bold>
<bold>Moderate DKA</bold>
</bold>
</bold>
</td>
                <td style="width: 120.078125px; height: 22px;" rowspan="1" colspan="1">
<bold>Severe DKA</bold>
</td>
              </tr>
              <tr style="height: 22px;">
                <td style="width: 127px; height: 22px;" rowspan="1" colspan="1">Venous pH</td>
                <td style="width: 117px; height: 22px;" rowspan="1" colspan="1">7.2 to &#x0003c;7.3</td>
                <td style="width: 117px; height: 22px;" rowspan="1" colspan="1">7.1 to &#x0003c;7.2</td>
                <td style="width: 120.078125px; height: 22px;" rowspan="1" colspan="1">&#x0003c;7.1</td>
              </tr>
              <tr style="height: 30px;">
                <td style="width: 127px; height: 30px;" rowspan="1" colspan="1">Serum bicarbonate (mEq/L)</td>
                <td style="width: 117px; height: 30px;" rowspan="1" colspan="1">10 to &#x0003c;15*</td>
                <td style="width: 117px; height: 30px;" rowspan="1" colspan="1">5 to 9</td>
                <td style="width: 120.078125px; height: 30px;" rowspan="1" colspan="1">&#x0003c;5*</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Table 1. The severity of diabetic ketoacidosis in children</p>
        <p>Higher thresholds for bicarbonate may be used for vulnerable patients such as those in resource-limited settings or in young children, e.g., bicarbonate &#x0003c;7 mEq/L for severe DKA and &#x0003c;18 mEq/L for mild DKA.</p>
      </sec>
      <sec id="article-26827.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment for DKA begins with ABCs and fluid resuscitation. Insulin therapy, usually by continuous infusion, can begin once the patient is stabilized.<xref ref-type="bibr" rid="article-26827.r1">[1]</xref><xref ref-type="bibr" rid="article-26827.r33">[33]</xref><xref ref-type="bibr" rid="article-26827.r34">[34]</xref><xref ref-type="bibr" rid="article-26827.r35">[35]</xref></p>
        <list list-type="order">
          <list-item>
            <p><bold>General resuscitation:</bold>&#x000a0;Provide&#x000a0;100% oxygen and consider intubation if needed. Insert a nasogastric tube and urinary catheter for comatose patients. Reliable intravenous (IV) access (preferably two large-bore accesses) should be obtained, one for insulin treatment and the other for blood samples and other medications.</p>
          </list-item>
          <list-item>
            <p><bold>Clinical assessment:</bold> Identify any signs of infection or other precipitating causes and treat as indicated.</p>
          </list-item>
          <list-item>
            <p>Precise <bold>patient weight</bold>&#x000a0;is necessary for calculating insulin and other medication dosing.</p>
          </list-item>
          <list-item>
            <p><bold>Insulin Therapy:</bold> Regular Insulin should be administered with a continuous drip at a rate of 0.1 unit/kg/hour.<xref ref-type="bibr" rid="article-26827.r27">[27]</xref> Subcutaneous insulin may be used in case of milder diabetic ketoacidosis or when IV infusion pumps are unavailable. Dextrose should be added to the IV fluid infusion when serum glucose concentration decreases to 250 mg/dL.<xref ref-type="bibr" rid="article-26827.r27">[27]</xref>&#x000a0;Higher concentrations of dextrose may be used, for example, 10 to 12.5%, when the blood glucose level falls below 150 mg/dL. This allows for complete resolution of ketoacidosis with continued insulin infusion. Ideally, the insulin infusion rate is reduced only after ketoacidosis is corrected or nearly corrected. However, in malnourished patients with increased sensitivity to insulin, insulin infusion rates may be decreased to avoid hypoglycemia. There is <italic toggle="yes">no role</italic> for insulin bolus in pediatric DKA patients &#x02013; this is thought to increase the risk of cerebral edema. Consider waiting to initiate insulin infusion until after serum potassium is known, thus preventing critical worsening of hypokalemia.</p>
          </list-item>
          <list-item>
            <p>The <bold>i</bold><bold>nsulin infusion is stopped</bold> when the following targets are achieved:
<list list-type="order"><list-item><p>The patient can take orally administered medications</p></list-item><list-item><p>Blood glucose less than 200 mg/dL</p></list-item><list-item><p>Serum anion gap closed or BHB less than or equal to 10.4 mg/dL</p></list-item><list-item><p>Venous pH &#x0003e;7.3 or serum bicarbonate &#x0003e;15 mEq/L</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>IV Fluids:&#x000a0; Treats dehydration and also hyperglycemia.
<list list-type="order"><list-item><p>Initial IV fluid bolus of 10 mL/kg of normal saline or lactated ringers.</p></list-item><list-item><p>If the patient presents with shock, a second 10 mL/kg IV fluid bolus may be given.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>As mentioned above, hyperglycemia contributes to <bold>pseudohyponatremia.&#x000a0;</bold>Therefore sodium should&#x000a0;be continuously monitored, and higher concentrations of sodium should be used in IV fluids if sodium levels do not improve or continue to fall with treatment.<xref ref-type="bibr" rid="article-26827.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Potassium replacement</bold> should depend on close observation and interpretation of lab values. If the initial potassium level reveals hyperkalemia, potassium replacement should be held until potassium normalizes, urinary voiding is confirmed to be intact, and there is normal renal function.&#x000a0; Normal initial potassium in an acidotic patient could indicate severely low total body potassium. Patients with normal or low&#x000a0;serum potassium require&#x000a0;replacement after ruling out renal dysfunction. DKA&#x000a0;patients with hypokalemia should have delayed initial insulin infusion; potassium replacement should precede insulin dosing as above.<xref ref-type="bibr" rid="article-26827.r27">[27]</xref>&#x000a0;The serum potassium concentration and electrocardiogram can be used for monitoring as needed.</p>
          </list-item>
          <list-item>
            <p><bold>Ketoacidosis</bold> is resolved when the anion gap is normal, serum BHB is &#x02264;10.4 mg/dL, and venous pH is &#x02265;7.3. It is achieved through decreased hepatic production of ketones, enhanced metabolism by insulin, and increased removal by improved rehydration.<xref ref-type="bibr" rid="article-26827.r27">[27]</xref><xref ref-type="bibr" rid="article-26827.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Lactic acidosis</bold> is also corrected with improved rehydration.</p>
          </list-item>
          <list-item>
            <p><bold>Bicarbonate</bold> therapy is generally avoided in&#x000a0;children with DKA except in peri-arrest or cardiac arrest patients, life-threatening hyperkalemia, or severe acidosis (pH &#x0003c;6.9 with symptoms).</p>
          </list-item>
          <list-item>
            <p>High-level <bold>nursing</bold> and frequent clinical assessments are necessary; biochemical blood markers every two hours.</p>
          </list-item>
          <list-item>
            <p>Once acidosis is resolved, the anion gap has closed, and the patient is improving clinically, then diet can be reintroduced, and insulin can be switched to <bold>subcutaneous injection. Long-acting/baseline insulin</bold> should be administered prior to discontinuation of the infusion.</p>
          </list-item>
          <list-item>
            <p><bold>Prevention:</bold> Determine the cause of the acute DKA episode and work closely with the child and caregivers on a regime.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26827.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Gastroenteritis</p>
          </list-item>
          <list-item>
            <p>Hyperosmolar hyperglycemic nonketotic syndrome</p>
          </list-item>
          <list-item>
            <p>Starvation ketosis</p>
          </list-item>
          <list-item>
            <p>Myocardial infarction</p>
          </list-item>
          <list-item>
            <p>Pancreatitis</p>
          </list-item>
          <list-item>
            <p>Alcoholic ketoacidosis</p>
          </list-item>
          <list-item>
            <p>Lactic acidosis</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Toxicologic exposure (ethylene glycol, methanol, paraldehyde, salicylate)</p>
          </list-item>
          <list-item>
            <p>Diabetic medication overdose</p>
          </list-item>
          <list-item>
            <p>Uremia</p>
          </list-item>
          <list-item>
            <p>Respiratory acidosis</p>
          </list-item>
          <list-item>
            <p>Respiratory distress syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26827.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis improves with advances in medical and intensive care. Mortality rates range from 0.15 to 0.31% in the United States and other resource-developed countries like Canada and United Kingdom.<xref ref-type="bibr" rid="article-26827.r38">[38]</xref>&#x000a0;The majority of deaths result from cerebral injury.<xref ref-type="bibr" rid="article-26827.r39">[39]</xref>&#x000a0;Mortality rates or higher and resource-limited settings.</p>
      </sec>
      <sec id="article-26827.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The most feared complication of pediatric DKA is cerebral injury/cerebral edema:</p>
        <list list-type="order">
          <list-item>
            <p>Develops in 0.3%-0.9% of pediatric DKA cases. <xref ref-type="bibr" rid="article-26827.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Mortality ranges from 21-24%<xref ref-type="bibr" rid="article-26827.r38">[38]</xref><xref ref-type="bibr" rid="article-26827.r40">[40]</xref><xref ref-type="bibr" rid="article-26827.r41">[41]</xref><xref ref-type="bibr" rid="article-26827.r40">[40]</xref><xref ref-type="bibr" rid="article-26827.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Risk factors:&#x000a0; Severe acidosis, severe dehydration, elevated blood pressure, markedly elevated BUN<xref ref-type="bibr" rid="article-26827.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>Etiology:&#x000a0; Unclear, however initially thought to be to due rapid IV fluid replacement but this is now controversial as a recent PECARN study in 2018 showed no difference in neurological outcomes.<xref ref-type="bibr" rid="article-26827.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p>Presents at any time before, during, or after treatment, but typically onset is within 12 hours of treatment.<xref ref-type="bibr" rid="article-26827.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>Signs/Symptoms:&#x000a0; Altered mental status, new headache, recurrent vomiting, urinary incontinence, Cushing Triad (bradycardia, irregular respirations, hypertension)</p>
          </list-item>
          <list-item>
            <p>Cerebral Edema may not initially be seen on CT imaging of the brain, therefore may still require starting treatment even if the CT head is normal.<xref ref-type="bibr" rid="article-26827.r43">[43]</xref></p>
          </list-item>
          <list-item>
            <p>Treat if high suspicion:
<list list-type="order"><list-item><p>Mannitol (0.5-1 g/kg IV over 15 minutes): Osmotic diuretic causing withdrawing water from the brain parencyma. May give a second dose if there is no initial response.</p></list-item><list-item><p>Hypertonic (3%) saline 2.5 mL/kg over 30 minutes</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Neurosurgical consultation</p>
          </list-item>
        </list>
        <p>Other Complications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cognitive impairment</p>
          </list-item>
          <list-item>
            <p>Venous thrombosis<xref ref-type="bibr" rid="article-26827.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>Pancreatic enzyme elevations</p>
          </list-item>
          <list-item>
            <p>Acute kidney injury<xref ref-type="bibr" rid="article-26827.r45">[45]</xref></p>
          </list-item>
          <list-item>
            <p>Hypokalemia</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Rhabdomyolysis</p>
          </list-item>
          <list-item>
            <p>Pulmonary edema</p>
          </list-item>
          <list-item>
            <p>Multiple organ dysfunction syndrome</p>
          </list-item>
          <list-item>
            <p>Cardiac arrhythmias</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26827.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Education on the disease process of diabetes, including short and long-term complications, should be given to all patients. Parents and children should be taught how and when to check glucose. They should receive education about&#x000a0;how to use oral hypoglycemic meds&#x000a0;and/or insulin, medication, side effects, and the importance of compliance. Dietitians, nurses, and multi-disciplinary home health can be essential team members in assisting with this education.</p>
      </sec>
      <sec id="article-26827.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Recurrent DKA is a&#x000a0;particular problem in adolescents and may be fatal. Early help is advised as soon as the DKA diagnosis is made.</p>
        <p>It may be precipitated by:</p>
        <list list-type="order">
          <list-item>
            <p>Poor compliance or understanding of insulin therapy</p>
          </list-item>
          <list-item>
            <p>Infections</p>
          </list-item>
          <list-item>
            <p>Alcohol and substance&#x000a0;use disorders</p>
          </list-item>
          <list-item>
            <p>Psychological stress and&#x000a0;lifestyle changes</p>
          </list-item>
          <list-item>
            <p>Psychiatric disorders</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26827.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pediatric diabetic ketoacidosis is a life-threatening disorder best managed by an interprofessional team that includes an emergency department clinician, endocrinologist, pediatrician, intensivist, critical care nursing staff, and pharmacists. These individuals are best managed in the ICU and monitored by nurses. Providers should investigate the cause of DKA while providing initial hydration and correction of acidosis. Primary caregivers, pharmacists, and diabetes educators must work together&#x000a0;to ensure that the patient is compliant with insulin therapy and monitoring. Nurses can provide dosing for inpatients and can counsel all patients. Pharmacists will verify dosing and monitor potential drug interactions, providing counsel to patient parents. All interprofessional team members are responsible for documenting their observations, interactions, and interventions and informing other team members regarding the case, so additional interventions can be instituted if necessary. Interprofessional care is the best methodology for patient management in pediatric diabetic ketoacidosis. [Level 5]</p>
        <p>Any interprofessional team member who detects a change in status should immediately document their findings in the patient's medical record and notify other team members so corrective action can be taken to ensure optimal outcomes in this potentially very ill patient population.<xref ref-type="bibr" rid="article-26827.r46">[46]</xref><xref ref-type="bibr" rid="article-26827.r28">[28]</xref><xref ref-type="bibr" rid="article-26827.r47">[47]</xref></p>
      </sec>
      <sec id="article-26827.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26827&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26827">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/diabetes/pediatric-diabetic-ketoacidosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26827">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26827/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26827">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26827.s18">
        <title>References</title>
        <ref id="article-26827.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abulebda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Whitfill</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Nitu</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lutfi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abu-Sultaneh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Improving Pediatric Diabetic Ketoacidosis Management in Community Emergency Departments Using a Simulation-Based Collaborative Improvement Program.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2021</year>
            <month>Nov</month>
            <day>01</day>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>543</fpage>
            <page-range>543-549</page-range>
            <pub-id pub-id-type="pmid">30870337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Subclinical cerebral edema in diabetic ketoacidosis in children.</article-title>
            <source>Clin Case Rep</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>264</fpage>
            <page-range>264-267</page-range>
            <pub-id pub-id-type="pmid">30847186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayer-Davis</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kahkoska</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Jefferies</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dabelea</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Balde</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>CX</given-names>
              </name>
              <name>
                <surname>Aschner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>19 Suppl 27</volume>
            <issue>Suppl 27</issue>
            <fpage>7</fpage>
            <page-range>7-19</page-range>
            <pub-id pub-id-type="pmid">30226024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cattell</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Krochak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Inman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Implementation and Evaluation of a Diabetic Ketoacidosis Order Set in Pediatric Type 1 Diabetes at a Tertiary Care Hospital: A Quality-Improvement Initiative.</article-title>
            <source>Can J Diabetes</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>297</fpage>
            <page-range>297-303</page-range>
            <pub-id pub-id-type="pmid">30777707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Buse</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Mathieu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pettus</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Battelino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ampudia-Blasco</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Bode</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Cariou</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Close</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Dandona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferrannini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fourlanos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grunberger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Kurian</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Oron</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Parkin</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Pieber</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Rodbard</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Schatz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Skyler</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Tamborlane</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Yokote</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Phillip</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.</article-title>
            <source>Diabetes Care</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>1147</fpage>
            <page-range>1147-1154</page-range>
            <pub-id pub-id-type="pmid">30728224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Zahrani</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Al Shaikh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Glycemic Control in Children and Youth With Type 1 Diabetes Mellitus in Saudi Arabia.</article-title>
            <source>Clin Med Insights Endocrinol Diabetes</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>1179551418825159</fpage>
            <pub-id pub-id-type="pmid">30718968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jawaid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sohaila</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mohammad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rabbani</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Frequency, clinical characteristics, biochemical findings and outcomes of DKA at the onset of type-1 DM in young children and adolescents living in a developing country - an experience from a pediatric emergency department.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2019</year>
            <month>Feb</month>
            <day>25</day>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-119</page-range>
            <pub-id pub-id-type="pmid">30699071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Dunger</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>The risk and outcome of cerebral oedema developing during diabetic ketoacidosis.</article-title>
            <source>Arch Dis Child</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-22</page-range>
            <pub-id pub-id-type="pmid">11420189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sapru</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gitelman</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dubin</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Flori</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>865</fpage>
            <page-range>865-72</page-range>
            <pub-id pub-id-type="pmid">16279364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfsdorf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <collab>American Diabetes Association</collab>
            </person-group>
            <article-title>Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association.</article-title>
            <source>Diabetes Care</source>
            <year>2006</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>1150</fpage>
            <page-range>1150-9</page-range>
            <pub-id pub-id-type="pmid">16644656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kao</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Amed</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incidence Trends of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes in British Columbia, Canada.</article-title>
            <source>J Pediatr</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>221</volume>
            <fpage>165</fpage>
            <page-range>165-173.e2</page-range>
            <pub-id pub-id-type="pmid">32446476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klingensmith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Petitti</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Pihoker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Imperatore</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dolan</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Dabelea</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study.</article-title>
            <source>Pediatrics</source>
            <year>2008</year>
            <month>May</month>
            <volume>121</volume>
            <issue>5</issue>
            <fpage>e1258</fpage>
            <page-range>e1258-66</page-range>
            <pub-id pub-id-type="pmid">18450868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mallare</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Cordice</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Kreitzer</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>591</fpage>
            <page-range>591-7</page-range>
            <pub-id pub-id-type="pmid">14552517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000e9;vy-Marchal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>A</given-names>
              </name>
              <collab>EURODIAB ACE Study Group. Europe and Diabetes</collab>
            </person-group>
            <article-title>Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes.</article-title>
            <source>Diabetologia</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>44 Suppl 3</volume>
            <fpage>B75</fpage>
            <page-range>B75-80</page-range>
            <pub-id pub-id-type="pmid">11724421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chase</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Mackenzie</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Walravens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Roback</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rewers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamman</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Klingensmith</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Predictors of acute complications in children with type 1 diabetes.</article-title>
            <source>JAMA</source>
            <year>2002</year>
            <month>May</month>
            <day>15</day>
            <volume>287</volume>
            <issue>19</issue>
            <fpage>2511</fpage>
            <page-range>2511-8</page-range>
            <pub-id pub-id-type="pmid">12020331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cengiz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wolfsdorf</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Haymond</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shanmugham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamborlane</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Willi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Seiple</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>DuBose</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>RW</given-names>
              </name>
              <collab>T1D Exchange Clinic Network</collab>
            </person-group>
            <article-title>Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>447</fpage>
            <page-range>447-54</page-range>
            <pub-id pub-id-type="pmid">23469984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neufeld</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Raffel</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Landon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YD</given-names>
              </name>
              <name>
                <surname>Vadheim</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Early presentation of type 2 diabetes in Mexican-American youth.</article-title>
            <source>Diabetes Care</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-6</page-range>
            <pub-id pub-id-type="pmid">9538974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression.</article-title>
            <source>N Engl J Med</source>
            <year>1973</year>
            <month>Oct</month>
            <day>18</day>
            <volume>289</volume>
            <issue>16</issue>
            <fpage>843</fpage>
            <page-range>843-4</page-range>
            <pub-id pub-id-type="pmid">4763428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kebler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Cadnapaphornchai</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dynamic changes in serum phosphorus levels in diabetic ketoacidosis.</article-title>
            <source>Am J Med</source>
            <year>1985</year>
            <month>Nov</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>571</fpage>
            <page-range>571-6</page-range>
            <pub-id pub-id-type="pmid">3933341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnes</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Goerge</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Smythe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alford</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Chisholm</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Ketoacidosis in pancreatectomized man.</article-title>
            <source>N Engl J Med</source>
            <year>1977</year>
            <month>Jun</month>
            <day>02</day>
            <volume>296</volume>
            <issue>22</issue>
            <fpage>1250</fpage>
            <page-range>1250-3</page-range>
            <pub-id pub-id-type="pmid">404553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miles</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Haymond</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Nissen</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Gerich</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man.</article-title>
            <source>J Clin Invest</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>1554</fpage>
            <page-range>1554-61</page-range>
            <pub-id pub-id-type="pmid">6134753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edgerton</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Ramnanan</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Grueter</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Lautz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Cherrington</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.</article-title>
            <source>Diabetes</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>2766</fpage>
            <page-range>2766-75</page-range>
            <pub-id pub-id-type="pmid">19755527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Owen</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Trapp</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Skutches</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Mozzoli</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hoeldtke</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Boden</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reichard</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Acetone metabolism during diabetic ketoacidosis.</article-title>
            <source>Diabetes</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>242</fpage>
            <page-range>242-8</page-range>
            <pub-id pub-id-type="pmid">6818074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kangin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Talay</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Tanriverdi Yilmaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Unal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Demiral</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozbek</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>A Retrospective Analysis of Children and Adolescents With Diabetic Ketoacidosis in the Intensive Care Un&#x00131;t: Is It Significant that the Blood Ketone Level Becomes Negative in Diabetic Ketoacidosis?</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Oct</month>
            <day>08</day>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>e10844</fpage>
            <pub-id pub-id-type="pmid">33178500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tantiwong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Puavilai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ongphiphadhanakul</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bunnag</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ngarmukos</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Capillary blood beta-hydroxybutyrate measurement by reagent strip in diagnosing diabetic ketoacidosis.</article-title>
            <source>Clin Lab Sci</source>
            <year>2005</year>
            <season>Summer</season>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>139</fpage>
            <page-range>139-44</page-range>
            <pub-id pub-id-type="pmid">16134474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bergomi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Ford-Adams</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Dunger</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Conscious level in children with diabetic ketoacidosis is related to severity of acidosis and not to blood glucose concentration.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-5</page-range>
            <pub-id pub-id-type="pmid">16489969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfsdorf</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Agus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fritsch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Codner</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>19 Suppl 27</volume>
            <fpage>155</fpage>
            <page-range>155-177</page-range>
            <pub-id pub-id-type="pmid">29900641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kuppermann</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Fluid treatment for children with diabetic ketoacidosis: How do the results of the pediatric emergency care applied research network Fluid Therapies Under Investigation in Diabetic Ketoacidosis (FLUID) Trial change our perspective?</article-title>
            <source>Pediatr Diabetes</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-14</page-range>
            <pub-id pub-id-type="pmid">30417497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbas</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Arbab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haque</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Humayun</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Spectrum of complications of severe DKA in children in pediatric Intensive Care Unit.</article-title>
            <source>Pak J Med Sci</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-109</page-range>
            <pub-id pub-id-type="pmid">29643888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baalaaji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jayashree</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nallasamy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Singhi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Predictors and Outcome of Acute Kidney Injury in Children with Diabetic Ketoacidosis.</article-title>
            <source>Indian Pediatr</source>
            <year>2018</year>
            <month>Apr</month>
            <day>15</day>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>311</fpage>
            <page-range>311-314</page-range>
            <pub-id pub-id-type="pmid">29428918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfsdorf</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>The International Society of Pediatric and Adolescent Diabetes guidelines for management of diabetic ketoacidosis: Do the guidelines need to be modified?</article-title>
            <source>Pediatr Diabetes</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>277</fpage>
            <page-range>277-86</page-range>
            <pub-id pub-id-type="pmid">24866064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dabelea</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pihoker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Talton</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Fujimoto</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Klingensmith</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marcovina</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Mayer-Davis</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Imperatore</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dolan</surname>
                <given-names>LM</given-names>
              </name>
              <collab>SEARCH for Diabetes in Youth Study</collab>
            </person-group>
            <article-title>Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study.</article-title>
            <source>Diabetes Care</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>7</issue>
            <fpage>1628</fpage>
            <page-range>1628-33</page-range>
            <pub-id pub-id-type="pmid">21636800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinberger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seick Barbarini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Simma</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Adherence to Guidelines in the Treatment of Diabetic Ketoacidosis in Children: An Austrian Survey.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>245</fpage>
            <page-range>245-249</page-range>
            <pub-id pub-id-type="pmid">30045350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunn</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Hofman</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Cutfield</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Jefferies</surname>
                <given-names>CA</given-names>
              </name>
              <collab>Starbase Diabetes Working Group, Paediatric Diabetes Service, Starship Children's Hospital, Auckland, New Zealand</collab>
            </person-group>
            <article-title>Pathways to reduce diabetic ketoacidosis with new onset type 1 diabetes: Evidence from a regional pediatric diabetes center: Auckland, New Zealand, 2010 to 2014.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>553</fpage>
            <page-range>553-558</page-range>
            <pub-id pub-id-type="pmid">27726271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abulebda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Abu-Sultaneh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Frye</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Lutfi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Disparities in Adherence to Pediatric Diabetic Ketoacidosis Management Guidelines Across a Spectrum of Emergency Departments in the State of Indiana: An Observational In Situ Simulation-Based Study.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2018</year>
            <month>Apr</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">29698339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glaser</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Stoner</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Garro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Trainor</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Quayle</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>McManemy</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>DePiero</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Nigrovic</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Tzimenatos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schunk</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Casper</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Ghetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuppermann</surname>
                <given-names>N</given-names>
              </name>
              <collab>Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group</collab>
            </person-group>
            <article-title>Serum Sodium Concentration and Mental Status in Children With Diabetic Ketoacidosis.</article-title>
            <source>Pediatrics</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>148</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">34373322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noyes</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Crofton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bath</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oxley</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Kelnar</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>150</fpage>
            <page-range>150-6</page-range>
            <pub-id pub-id-type="pmid">17550425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lawrence</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Gaboury</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Daneman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis.</article-title>
            <source>J Pediatr</source>
            <year>2005</year>
            <month>May</month>
            <volume>146</volume>
            <issue>5</issue>
            <fpage>688</fpage>
            <page-range>688-92</page-range>
            <pub-id pub-id-type="pmid">15870676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barnett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McCaslin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Trainor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Louie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Quayle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roback</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuppermann</surname>
                <given-names>N</given-names>
              </name>
              <collab>Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics</collab>
            </person-group>
            <article-title>Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Jan</month>
            <day>25</day>
            <volume>344</volume>
            <issue>4</issue>
            <fpage>264</fpage>
            <page-range>264-9</page-range>
            <pub-id pub-id-type="pmid">11172153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barnett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McCaslin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Trainor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Louie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Quayle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roback</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuppermann</surname>
                <given-names>N</given-names>
              </name>
              <collab>American Academy of Pediatrics. The Pediatric Emergency Medicine Collaborative Research Commitee</collab>
            </person-group>
            <article-title>Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema.</article-title>
            <source>J Pediatr</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>141</volume>
            <issue>6</issue>
            <fpage>793</fpage>
            <page-range>793-7</page-range>
            <pub-id pub-id-type="pmid">12461495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scibilia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Finegold</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dorman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Drash</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Why do children with diabetes die?</article-title>
            <source>Acta Endocrinol Suppl (Copenh)</source>
            <year>1986</year>
            <volume>279</volume>
            <fpage>326</fpage>
            <page-range>326-33</page-range>
            <pub-id pub-id-type="pmid">3096039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuppermann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ghetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schunk</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Stoner</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McManemy</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Nigrovic</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Garro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Quayle</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Trainor</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Tzimenatos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>DePiero</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Casper</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>NS</given-names>
              </name>
              <collab>PECARN DKA FLUID Study Group</collab>
            </person-group>
            <article-title>Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Jun</month>
            <day>14</day>
            <volume>378</volume>
            <issue>24</issue>
            <fpage>2275</fpage>
            <page-range>2275-2287</page-range>
            <pub-id pub-id-type="pmid">29897851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krane</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rockoff</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wallman</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Wolfsdorf</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Subclinical brain swelling in children during treatment of diabetic ketoacidosis.</article-title>
            <source>N Engl J Med</source>
            <year>1985</year>
            <month>May</month>
            <day>02</day>
            <volume>312</volume>
            <issue>18</issue>
            <fpage>1147</fpage>
            <page-range>1147-51</page-range>
            <pub-id pub-id-type="pmid">3920521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Worly</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fortenberry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chambliss</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Stockwell</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters.</article-title>
            <source>Pediatrics</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>113</volume>
            <issue>1 Pt 1</issue>
            <fpage>e57</fpage>
            <page-range>e57-60</page-range>
            <pub-id pub-id-type="pmid">14702496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hursh</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Ronsley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mammen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Panagiotopoulos</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Acute Kidney Injury in Children With Type 1 Diabetes Hospitalized for Diabetic Ketoacidosis.</article-title>
            <source>JAMA Pediatr</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>171</volume>
            <issue>5</issue>
            <fpage>e170020</fpage>
            <pub-id pub-id-type="pmid">28288246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Clements</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rickels</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>DiMeglio</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Maahs</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Tamborlane</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Bergenstal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.</article-title>
            <source>Diabetes Technol Ther</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>66</fpage>
            <page-range>66-72</page-range>
            <pub-id pub-id-type="pmid">30657336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26827.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sildorf</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Breinegaard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lindkvist</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Tolstrup</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Boisen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Teilmann</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Skovgaard</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Poor Metabolic Control in Children and Adolescents With Type 1 Diabetes and Psychiatric Comorbidity.</article-title>
            <source>Diabetes Care</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>11</issue>
            <fpage>2289</fpage>
            <page-range>2289-2296</page-range>
            <pub-id pub-id-type="pmid">30270201</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
